Gabapentin

January 8, 2018 by C. Scott McMillin

You might say the drug itself may not be that dangerous, except to our patients. 

Topics: , ,


Beware Lookalikes

December 14, 2017 by C. Scott McMillin

It’s also not too difficult to create a ‘homemade’ variety using raw ingredients purchased on the dark web and a common pill press.

Topics: , , ,


Searching for a Substitute

November 30, 2017 by C. Scott McMillin

If addiction really is a brain disorder based in complex adaptations to a substance, then who’s to say those adaptations won’t occur with a different drug?

Topics: , , , ,


Naltrexone versus Opioids

November 27, 2017 by C. Scott McMillin

Not surprisingly, the vast majority of patients who drop out or otherwise leave maintenance programs return to heroin at rates of 80% or higher.

Topics: , , ,


Cannabis and the Political Class

October 30, 2017 by C. Scott McMillin

If we’re going to rely on science in decision-making, we should at least make certain it’s good science.

Topics: ,


In the News: Fentanyl Epidemic

September 18, 2017 by C. Scott McMillin

Then word hits the street of a new product that can make you feel almost like your first time… No wonder they come running. And some never wake up.

Topics: ,


Another Turn of the Cycle

July 24, 2017 by C. Scott McMillin

Of course, we still lose several hundred thousand people annually. But that’s actually progress.

Topics: ,


Cannabis Treatment

July 13, 2017 by C. Scott McMillin

…we should be looking at modifying our historical approach to the addicted cannabis client, away from emphasis on legal consequences and mandated compliance, and towards a more patient-centered model.

Topics: , ,


Extraordinary Delusions

May 1, 2017 by C. Scott McMillin

In one state that legalized cannabis, price has now fallen 25% and continues to drop.

Topics: ,


Pot Potency

March 30, 2017 by C. Scott McMillin

Producers and distributors are eager to attract the higher-end customer, mostly likely an adult daily user who needs stronger pot to manage dependence on the drug.

Topics: ,


Subscribe to RecoverySI via Email

Join 821 other subscribers


New Content